High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression von Boultwood, J, Perry, J, Zaman, R, Fernandez-Santamaria, C, Littlewood, T, Kusec, R, Pellagatti, A, Wang, L, Clark, R E, Wainscoat, J S

Volltext

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation von Campbell, Peter J., Baxter, E. Joanna, Beer, Philip A., Scott, Linda M., Bench, Anthony J., Huntly, Brian J.P., Erber, Wendy N., Kusec, Rajko, Larsen, Thomas Stauffer, Giraudier, Stéphane, Le Bousse-Kerdilès, Marie-Caroline, Griesshammer, Martin, Reilly, John T., Cheung, Betty Y., Harrison, Claire N., Green, Anthony R.

Volltext

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R‐DA‐EPOCH von Sabljic, A., Sedinic, M., Kusec, R., Pejsa, V., Lucijanic, M.

Volltext

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes von Dolatshad, H, Pellagatti, A, Liberante, F G, Llorian, M, Repapi, E, Steeples, V, Roy, S, Scifo, L, Armstrong, R N, Shaw, J, Yip, B H, Killick, S, Kušec, R, Taylor, S, Mills, K I, Savage, K I, Smith, C W J, Boultwood, J

Volltext

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS von Lucijanic, M., Krecak, I., Soric, E., Galusic, D., Holik, H., Perisa, V., Moric Peric, M., Zekanovic, I., Kusec, R.

Volltext

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS von Lucijanic, M., Krecak, I., Soric, E., Galusic, D., Holik, H., Perisa, V., Moric Peric, M., Zekanovic, I., Kusec, R.

Volltext

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID‐19 PATIENTS von Lucijanic, M., Jurin, I., Sedinic, M., Soric, E., Sabljic, A., Hadzibegovic, I., Lucijanic, T., Kusec, R.

Volltext

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID‐19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY von Lucijanic, M., Soric, E., Sedinic, M., Sabljic, A., Tomasinec, S., Pasaric, A., Ivic, M., Vasilj, T., Cicic, D., Jonjic, Z., Pirsic, M., Mitrovic, Z., Prka, Z., Pejsa, V., Kusec, R., Jaksic, O.

Volltext

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET) von Barosi, Giovanni, Bordessoule, Dominique, Briere, Jean, Cervantes, Francisco, Demory, Jean-Loup, Dupriez, Brigitte, Gisslinger, Heinz, Griesshammer, Martin, Hasselbalch, Hans, Kusec, Rajko, Le Bousse-Kerdiles, Marie-Caroline, Liberato, Nicola L., Marchetti, Monia, Reilly, John T., Thiele, Jurgen

Volltext

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia von CAMPBELL, L. J, FIDLER, C, EAGLETON, H, PENIKET, A, KUSEC, R, GAL, S, LITTLEWOOD, T. J, WAINSCOAT, J. S, BOULTWOOD, J

Volltext

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Fea... von Lucijanic, Marko, Korunic, Renata Huzjan, Sedinic, Martina, Kusec, Rajko, Pejsa, Vlatko

Volltext

37 Diffuse skin hyperpigmentation in CD30+ lymphoproliferation: A case report von Prka, Z, Tomasovic-Loncaric, C, Pejsa, V, Nevajda, B, Kusec, R

Volltext

IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM ON BLOOD PRESSURE AND PROTEIN EXCRETION IN PATIENTS WITH OVERT PROTEINURIA: PP.25.289 von Zivko, M., Kusec, R., Galesic, K.

Volltext

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia von SCHMID, D, HEINZE, G, MANNHALTER, C, HAAS, O. A, LECHNER, K, JÄGER, U, GAIGER, A, LINNERTH, B, TISLJAR, K, KUSEC, R, GEISSLER, K, SILLABER, C, LACZIKA, K, MITTERBAUER, M, ZÖCHBAUER, S

Volltext

P034 Bone marrow renin-angiotensin system expression in polycythaemia vera and essential thrombocythaemia depends on JAK2 mutational status von Marusic Vrsalovic, M, Pejsa, V, Stoos Veic, T, Ostojic Kolonic, S, Ajduković, R, Haris, V, Jaksic, O, Kusec, R

Volltext

P041 Molecular detection and clinics of IgH/MMSET of t(4;14)(4p16;14q32) in multiple myeloma von Kusec, R, Livun, A, Marusic Vrsalovic, M, Ostojic Kolonic, S, Haris, V, Ajduković, R, Jaksic, O, Pejsa, V

Volltext

561 Renin-angiotensin system expression in myeloproliferative diseases von Marijanovic, I, Marusic Vrsalovic, M, Caput Mihalic, K, Matic, I, Antunovic, M, Kusec, R, Nagy, B

Volltext

Telomere length in myelodysplastic syndromes von Boultwood, J., Fidler, C., Kusec, R., Rack, K., Elliott, P.J. W., Atoyebi, O., Chapman, R., Oscier, D. G., Wainscoat, J. S.

Volltext

PS1452 GLI‐1, EFFECTOR OF CANONICAL HEDGEHOG SIGNALING PATHWAY, DOES NOT SEEM TO BE DYSREGULATED IN PATIENTS WITH MYELOFIBROSIS von Lucijanic, M., Livun, A., Stoos‐Veic, T., Pejsa, V., Jonjic, Z., Dzankic, A. Fazlic, Ivic, M., Kusec, R.

Volltext

The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia von Svoboda-Beusan, I, Kusec, R, Bendelja, K, Tudoric-Ghemo, I, Jaksic, B, Pejsa, V, Rabatic, S, Vitale, B

Volltext